Localization and Expression of Renin-Angiotensin System Receptors in Lung from Transplant Patients: A Case-Control...

Area of Science:

• Pulmonary Medicine
• Cardiovascular Research
• Molecular Biology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
• The renin-angiotensin system (RAS) plays a role in cardiovascular and renal function, but its role in lung tissue, particularly in IPF, is not fully understood.

Purpose of the Study:

• To investigate the expression and localization of key RAS receptors (AT1, Mas, MrgD) in the lung tissue of IPF patients.
• To compare plasma concentrations of RAS-related peptides between IPF patients and controls.
• To correlate lung receptor expression with clinical parameters like lung function and oxygen dependence.

Main Methods:

• Case-control study involving 19 IPF patients undergoing lung surgery or transplantation.
• Measurement of plasma peptides (Angiotensin I, II, A, 1-7, Alamandine) using liquid chromatography-tandem mass spectrometry.
• Evaluation of lung tissue receptor expression (AT1, Mas, MrgD) via Western blot and immunohistochemistry.

Main Results:

• IPF patients exhibited significantly reduced lung function (FVC, FEV1) and increased oxygen dependence.
• Plasma peptide levels were largely similar, with higher Angiotensin I in controls.
• IPF lung tissue showed increased expression of angiotensin type 1 (AT1) and Mas receptors, and decreased MrgD expression.
• Mas receptors were localized to bronchioles, while MrgD was predominant in the lung parenchyma.

Conclusions:

• The renin-angiotensin system (RAS) exhibits distinct tissue-specific activity in the lungs, separate from its systemic functions.
• Altered expression and localization of Mas and MrgD receptors in IPF lungs suggest their potential involvement in disease pathogenesis.
• Targeting these specific RAS receptors in lung tissue may represent a novel therapeutic strategy for IPF.